The field of musculoskeletal medicine is undergoing a significant transformation with the advent of regenerative therapies. This chapter explores the current landscape and future potential of regenerative medicine in addressing musculoskeletal disorders (MSDs), focusing on stem cell therapies, platelet-rich plasma (PRP), and advancements in biomaterials and tissue engineering. Traditional treatments, such as surgery and pharmacological interventions, often fail to address the underlying causes of tissue degeneration and have notable limitations, including high recurrence rates and side effects. Regenerative medicine offers an alternative by promoting the repair and regeneration of damaged tissues. Key innovations, such as 3D bioprinting and gene editing technologies like CRISPR-Cas9, are enhancing the precision and effectiveness of these therapies. Despite the promise, challenges remain in terms of clinical standardisation, regulatory hurdles, and patient education. As research progresses, the integration of personalised treatments, enhanced biomaterials, and advanced drug delivery systems is expected to improve therapeutic outcomes, reduce healthcare costs, and offer more accessible solutions. This chapter concludes by discussing the broad potential impact of regenerative medicine on healthcare, emphasising the need for continued innovation and ethical considerations to ensure equitable access to these emerging treatments. The future of musculoskeletal medicine is poised to shift toward more effective, minimally invasive, and regenerative solutions.